Fernandes-Osterhold G
Translational Psychedelic Research Program, Department of Psychiatry and Behavioral Sciences, Weill Institute for Neurosciences, University of California, San Francisco.
ArticlePsilocybin
An Open-Label, Dose-Escalation Trial of Psilocybin-Assisted Therapy for Bipolar II Depression.
ArticlePsilocybin
A randomized crossover trial comparing the acute physiological and psychological effects of botanical formulations of oral psilocybin, oral psilocin, and sublingual psilocin.
ArticleKetamine
Exploratory non-randomized clinical trial of subcutaneous esketamine in treatment-resistant depression: Effects of ketamine-assisted psychotherapy.
PreprintKetamine
Preliminary Non-Randomized Clinical Trial of Subcutaneous Esketamine in Treatment-Resistant Depression: Exploring Adjunctive Effects of Ketamine-Assisted Psychotherapy
ArticlePsilocybin
Mapping cognitive-behavioral approach in psychedelic-assisted treatment: a systematic review across phases with classic and non-classic psychedelics.
PreprintMDMA
MDMA-assisted Acceptance and Commitment Therapy for Posttraumatic Stress Disorder: Rationale for a New Approach
ArticlePsychedelics
Leveraging family and caregiver support in psychedelic-assisted therapy: considerations for the treatment of adolescents.
ArticlePsilocybin
Psilocybin therapy for mood dysfunction in Parkinson's disease: an open-label pilot trial.
ArticlePsilocybin
Psychedelics assisting therapy, or therapy assisting psychedelics? The importance of psychotherapy in psychedelic-assisted therapy.
ArticlePsilocybin
A systematic review of participant diversity in psychedelic-assisted psychotherapy trials.
ArticleKetamine
Ketamine's Altered States Meta-Analysis: The Relationship Between Psychomimetic and Clinical Effects With Focus in Depression.
ArticlePsilocybin
Psychedelic-assisted psychotherapy: where is the psychotherapy research?
ArticlePsilocybin